Population pharmacokinetics of methotrexate and 7-hydroxymethotrexate and delayed excretion in infants and young children with brain tumors
CONCLUSIONS: MTX and 7OHMTX plasma disposition were characterized for the first time in young children with brain tumors. No exposure-toxicity relationship was identified in this study, presumably due to aggressive clinical management which led to a low MTX-related toxicity rate.PMID:38070781 | DOI:10.1016/j.ejps.2023.106669
Source: European Journal of Pharmaceutical Sciences - Category: Drugs & Pharmacology Authors: Olivia Campagne Jie Huang Tong Lin Wilburn E Reddick Nicholas S Selvo Arzu Onar-Thomas Deborah Ward Giles Robinson Amar Gajjar Clinton F Stewart Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Children | Drugs & Pharmacology | Genetics | Laboratory Medicine | Methotrexate | Neurology | Study | Toxicology